Big money tends to bring out the big guns.
That was evident at a lengthy hearing on Nov. 22 before U.S. District Judge Thomas F. Hogan, of Washington, D.C., who is overseeing the $1.17 billion settlement of a massive class action that accuses the world’s leading vitamin makers of a global price-fixing conspiracy. High-priced legal talent from firms such as Washington, D.C.’s Williams & Connolly and Howrey & Simon packed his courtroom to attack a provision to allow at least 96 companies to opt out of the settlement to recover greater damages.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]